Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
 
 
January 19, Friday 2018 8:55 PM       

       HEADLINES: Why we need these MPs to talk only in channels, asks K Surendran                                              B Sandhya removed as ADGP, South                                              Was son killed over property dispute? Police unwilling to accept Jaya's statement                                              CBI will probe Sreejiv’s death, order passed                                              Actress attack case: No action on Dileep’s complaint on charge sheet leak                                              Fire breaks out in Mumbai's Navrang Studio                                              Solution to SC judges’ row likely on Monday                                              EC has never touched this low: AAP                                              Hafiz Saeed should be prosecuted: US                                              India should not comment on Chinese construction in Doklam: Beijing                                              Pak-Iran to resume rail services                                              Kulbhushan Jadhav abducted from Iran: Baloch activist                                              ICC U-19 WC: India thrash Zimbabwe to top Group B                                              We will definitely try to get Ashwin back in CSK: Dhoni                                              AIFF U-16 team departs for exposure trip to Dubai                                              Kaumudi Facebook
       SCI&TECH Next Article: Threat of asteroid impact looming over Earth: experts  
       New drug to treat blood cancer developed
 
         Posted on :19:38:19 Jun 10, 2017
   
A A
       Last edited on:19:38:19 Jun 10, 2017
         Tags: New drug, blood cancer
 
NEW YORK: A new drug for blood cancer that may provide better treatment alone or combined with chemotherapy has been developed by a team led by an Indian-origin scientist.
 
Acute lymphoblastic leukemia or ALL can affect both children and adults.
 
Scientists have found up to 30 per cent of adult ALL patients have what is called a Philadelphia chromosome, where two segments of chromosomes have aberrantly fused together. The ALL cancer cells containing the Philadelphia chromosome are addicted to repairing DNA.
 
"Repairing DNA may sound like a good thing when you are talking about healthy cells. But in this case it is a bad thing. When you treat these leukemia cells with chemotherapy, you want DNA damage to accumulate so the cancer cells will die," said Srividya Bhaskara, a post doctoral at University of Utah in the US.
 
"However, because the Philadelphia chromosome continually causes repair, these cells do not retain enough DNA damage to die. Essentially they resist any kind of drug you use on them. So we had to find a new way to overcome this DNA repair addiction," she said.
 
Researchers found that the Philadelphia chromosome promotes repair through numerous proteins. But putting together a cocktail of drugs to inhibit them all would likely be too toxic and affect normal cells.
 
Bhaskara focused on two specific proteins she found were directly involved in DNA repair, called histone deacetylases (HDAC) 1 and 2. She then collaborated with a company to make a drug that inhibits HDAC1,2 activity.
 
After a comprehensive analysis of how the drug worked, Bhaskara tested the HDAC1,2 inhibitor in patient samples and mice and saw encouraging results, either alone or in combination with a chemotherapy drug called doxorubicin.
 
Doxorubicin is one of the components of the chemotherapy cocktail regimen currently used for Philadelphia chromosome-positive ALL patients.
 
Researchers found that the drugs broke down the central hub of DNA repair, and the HDAC1,2 inhibitor actually reduced different repair protein functions.
 
"The treated mice did not get sick from the drug, and we did not see any apparent toxic side-effects in them. And when the drug was combined with a low concentration of doxorubicin, it had additional therapeutic benefits," Bhaskara said.
 
"We actually show in the patient-derived mouse models that using the combination of drugs, or HDAC1,2 inhibitor alone, is sufficient to decrease the leukemia load," she said.
 
Leukemia is a white blood cell disease where the body produces too many white and not enough red blood cells.
 
When the mice in this study were treated with the HDAC1,2 inhibitor or the HDAC1,2/doxorubicin combination, their bone marrow started turning from pale to red, indicating the white blood cells were being replaced with red blood cells, researchers said.
 
"We completely nailed down how the HDAC1,2 inhibitor affects DNA repair. This is so important, not just for this cancer, but any cancer that is repair-addicted. We know there is a specific type of lymphoma that is also repair-addicted," Bhaskara said.
 
The study was published in the journal Leukemia.
A A
       SCI&TECH
Next Article: Threat of asteroid impact looming over Earth: experts
 
 
SCI&TECH HEADLINES
Secret of longevity protein revealed!  
Absence of this gene can give men deadly cancer  
Soon, you can demote group admins on WhatsApp  
Regular yoga can slow down ageing of brain: Study  
What are haemorrhoids (piles) and what causes them?  
WhatsApp facilitates quick switch from voice to video call  
The Thin and Light Lenovo Ideapad 720s shines at Digit Zero 1 Awards  
Frequent heartburns up cancer risk in older adults  
Blueberry vinegar can help fight dementia  
iPhones with older batteries will take a hit in performance: Apple  
Eighth planet found in faraway solar system, matching ours  
Google brings a host of new features on Pixel 2  
Scientists turn beer into suitable petrol  
Space gives a sense of humbleness: NASA astronaut  
Researchers discover genes to prolong human life  
Google announces best apps of 2017  
This technology can help to reduce accidents on icy roads  
Yepzon launches in India; promises smart safety solutions  
Soon, you'll be able to control diabetes with your phone  
Turning bacteria into 'world's smallest tape recorders'  
How breastmilk protects babies from food allergy decoded  
Stars among the oldest in our galaxy discovered  
Apple delays release of smart speaker - HomePod  
Owning a dog may add years to your life  
'Textisms' actually add meaning to written words  
 
Do you think even today police resort to third degree torture to prove crime?
yes
 
no
 
no opinion
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy